Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Revenue (2020 - 2025)

Historic Revenue for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to -$815000.0.

  • Pliant Therapeutics' Revenue changed N/A to -$815000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2023, which is 8368.61% down from last year.
  • As of Q3 2025, Pliant Therapeutics' Revenue stood at -$815000.0.
  • Pliant Therapeutics' 5-year Revenue high stood at $5.0 million for Q2 2022, and its period low was -$815000.0 during Q3 2025.
  • For the 4-year period, Pliant Therapeutics' Revenue averaged around $1.3 million, with its median value being $1.5 million (2022).
  • Per our database at Business Quant, Pliant Therapeutics' Revenue skyrocketed by 17887.09% in 2022 and then plummeted by 9502.91% in 2023.
  • Quarter analysis of 4 years shows Pliant Therapeutics' Revenue stood at $2.0 million in 2021, then fell by 1.7% to $2.0 million in 2022, then plummeted by 87.38% to $248000.0 in 2023, then tumbled by 428.63% to -$815000.0 in 2025.
  • Its last three reported values are -$815000.0 in Q3 2025, -$809000.0 for Q2 2025, and -$799000.0 during Q1 2025.